Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo.
about
The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanismsNovel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascadeSynergistic suppression of early phase of adipogenesis by microsomal PGE synthase-1 (PTGES1)-produced PGE2 and aldo-keto reductase 1B3-produced PGF2α.Targeting steroid receptor coactivator 1 with antisense oligonucleotides increases insulin-stimulated skeletal muscle glucose uptake in chow-fed and high-fat-fed male ratsExtended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parametersProstaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans.PGD synthase and PGD2 in immune resposne.Aldo-Keto Reductases 1B in Endocrinology and Metabolism.Depressed levels of prostaglandin F2α in mice lacking Akr1b7 increase basal adiposity and predispose to diet-induced obesity.Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis.Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis.Prostaglandins as PPARγ Modulators in Adipogenesis.Obesity-induced changes in lipid mediators persist after weight loss.Sensitive mass spectrometric assay for determination of 15-deoxy-Δ(12,14)-prostaglandin J2 and its application in human plasma samples of patients with diabetes.Dietary polyunsaturated fatty acids and their metabolites: Implications for diabetes pathophysiology, prevention, and treatment.
P2860
Q27021538-DD62212A-89EB-4976-87EF-68520FCF1CD0Q28586698-7B368BEE-AE05-4EFB-B61B-062B3E12A6D2Q34412709-21C70C25-03B7-4A59-B8F7-65E7D0E2C3CCQ34439547-636AC28C-0F56-47B9-88A3-8EBF33D8F156Q35440499-33AA57BC-B7E3-4C33-A782-D8F4AA7D9472Q35801376-536D11AA-09FE-4FD2-8C58-EE1870FFFC85Q36076180-FA175382-5714-46EA-AC5D-6E4C145905D6Q36135903-4C837B6E-ABE7-42CE-AADA-323BD276ECEEQ36339464-2CD2692C-3D7F-46B3-BBDD-E6299F357B02Q37946729-FF47310D-12A7-48EB-9414-F0771CD7221EQ39360190-4B82E204-97E1-44B7-9C7C-856C9D288538Q41873873-C15890AF-9EC3-408A-875D-00D8FA136CEFQ45961332-B1BFB444-C667-4E9C-855B-8E34BBF5C96DQ46260464-53538B62-8ED1-4BF3-B980-E8B885626EC4Q54077093-9F3092E9-B6C5-4D62-BA00-34C65A7F57D6
P2860
Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Pronounced adipogenesis and in ...... n of prostaglandin D2 in vivo.
@en
Pronounced adipogenesis and in ...... n of prostaglandin D2 in vivo.
@nl
type
label
Pronounced adipogenesis and in ...... n of prostaglandin D2 in vivo.
@en
Pronounced adipogenesis and in ...... n of prostaglandin D2 in vivo.
@nl
prefLabel
Pronounced adipogenesis and in ...... n of prostaglandin D2 in vivo.
@en
Pronounced adipogenesis and in ...... n of prostaglandin D2 in vivo.
@nl
P2093
P2860
P50
P1433
P1476
Pronounced adipogenesis and in ...... on of prostaglandin D2 in vivo
@en
P2093
Kosuke Aritake
Teruo Kawada
Yasushi Fujitani
Yoshihide Kanaoka
P2860
P304
P356
10.1111/J.1742-4658.2010.07565.X
P407
P577
2010-02-03T00:00:00Z